Effects of short-term exposure to the model anti-androgen, flutamide on reproductive function based endpoints in female Murray rainbowfish (Melanotaenia fluviatilis)

• Absence of mature oocytes in flutamide-exposed fish.
• Decline in plasma vitellogenin concentration and brain aromatase activity after exposure to 500 and 1000 µg/L flutamide.
• Hormonal imbalance in flutamide-exposed female fish as suggested by low levels of 17β-Estradiol.

The aim of the present study was to evaluate the responses of female Murray rainbowfish (Melanotaenia fluviatilis) to the model anti-androgen, flutamide in a short-term exposure. Adult female Murray rainbowfish were exposed to nominal (measured) concentrations of 125 (104), 250 (163), 500 (378) and 1000 (769) µg/L of flutamide for seven days in a semi-static set-up. Plasma vitellogenin (VTG), 11-keto testosterone (11-KT) and 17β-estradiol (E2) concentrations, brain aromatase activity and ovarian histology were assessed following the exposure. No treatment-related mortality was found in rainbowfish and there was no effect of flutamide on the developmental stage of the ovaries. Histological investigation revealed absence of mature oocytes in flutamide-treated fish. In addition, a significant reduction in the sizes of the vitellogenic oocytes was found after treatment with 500 and 1000 µg/L flutamide. The circulating levels of VTG and the activity of aromatase in the brain were also significantly reduced in fish treated with 500 and 1000 µg/L flutamide. Treatment with higher concentrations of flutamide reduced the levels of 11-KT and E2 in plasma. The results from this study demonstrate that a short-term exposure to the model anti-androgen, flutamide can adversely affect the reproductive function based on end-points such as plasma VTG, 11-KT and E2; brain aromatase activity and sizes of the oocytes in female Murray rainbowfish. Further, a positive correlation between these experimental variables suggests hormonal imbalance.